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Abstract
Background: The zinc transporter ZIP4 (Slc39a4) is important for proper mammalian development and is an essential gene
in mice. Recent studies suggest that this gene may also play a role in pancreatic cancer.
Methods/Principal Findings: Herein, we present evidence that this essential zinc transporter is expressed in hepatocellular
carcinomas. Zip4 mRNA and protein were dramatically elevated in hepatocytes in the majority of human hepatocellular
carcinomas relative to noncancerous surrounding tissues, as well as in hepatocytes in hepatocellular carcinomas occurring
in farnesoid X receptor-knockout mice. Interestingly, meta-analysis of microarray data in the Geo and Oncomine databases
suggests that Zip4 mRNA may also be elevated in many types of cancer. Potential mechanisms of action of ZIP4 were
examined in cultured cell lines. RNAi knockdown of Zip4 in mouse Hepa cells significantly increased apoptosis and modestly
slowed progression from G0/G1 to S phase when cells were released from hydroxyurea block into zinc-deficient medium.
Cell migration assays revealed that RNAi knockdown of Zip4 in Hepa cells depressed in vitro migration whereas forced over-
expression in Hepa cells and MCF-7 cells enhanced in vitro migration.
Conclusions: ZIP4 may play a role in the acquisition of zinc by hepatocellular carcinomas, and potentially many different
cancerous cell-types, leading to repressed apoptosis, enhanced growth rate and enhanced invasive behavior.
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Introduction
Zinc is essential for the structure and function of literally
hundreds of proteins [1]. Therefore, changes in zinc availability
alter numerous cellular processes. Multiple genes have evolved to
control the storage (Metallothionein genes), efflux (Slc30a; Znt genes)
and uptake (Slc39a; Zip genes) of this metal (Reviewed by [2]).
Recent studies also reveal that zinc can be stored and released
from intracellular vesicular compartments and can function as a
novel intracellular second messenger [3,4]. For example, zinc
appears to be essential for lipopolysaccharide induced signal
transduction in monocytes and to influence IFN-c expression in
activated T-cells, and in mast cells labile zinc plays a role in regu-
lation of caspase activation and NF-kB translocation (Reviewed by
[5]). In the brain, synaptically released zinc triggers a metabotro-
pic signal [6]. Zinc can modulate the proliferation and
differentiation of mammalian cells by affecting several growth
factor signaling cascades [7]. The mechanism by which zinc exerts
these effects is an area of active investigation. Zinc can affect signal
recognition, second messenger metabolism, protein kinase and
protein phosphatase activities and transcription factor activity
[5,8–10].
Given the diversity of functions of zinc it is perhaps not
surprising that zinc transporters have recently been found to play
roles in carcinogenesis [2,10,11], as well as in embryonic
development (Reviewed by [12]). For example, ZIP1, ZIP4,
ZIP6, ZIP7 and ZIP10, members of the Zrt-Irt-like protein
(Slc39a) superfamily [2], have each been implicated in specific
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13158
cancers. ZIP1 is repressed in prostate cancer [11]. Aberrant
accumulation of ZIP4 has been reported to contribute to the
progression and aggressiveness of pancreatic cancer [13–16]. ZIP6
and ZIP7 may play roles in metastasis of estrogen receptor-positive
breast cancer [10,17] as well as in the proliferation, migration and
invasion of cervical cancer [18]. Similarly, ZIP10 has been shown
to affect the invasive behavior of breast cancer cells [19]. With
regard to embryonic development, mutations in human ZIP4
cause the lethal genetic disorder of zinc metabolism acrodermatitis
enteropathica, and the mouse Zip4 gene is essential for proper
early morphogenesis of the mouse embryo [20,21]. To date Zip4 is
the only mammalian ZIP superfamily member which has been
shown to be an essential gene; one that plays a fundamental role in
adaptation to zinc deficiency. However, the fear-of-intimacy gene in
Drosophila encodes a ZIP6-like zinc transporter that is essential
during early development and plays a role in migration of germ
cells [22]. Similarly, in zebrafish, a member of the ZIP superfamily
(zLIV-1) is essential during early morphogenesis and plays a role in
the epithelial-mesenchymal transition (EMT) during gastrulation
[23].
Given the fundamental role of ZIP4 in mammalian develop-
ment and adaptation to zinc deficiency, and the recent report of its
role in pancreatic cancer, we examined whether this gene may
play a fundamental role in carcinogenesis. Herein, we report that
the Zip4 gene is also actively expressed in hepatocytes in human
and mouse hepatocellular carcinomas (HCC), and meta-analyses
of the Geo and Oncomine databases further suggested that
enhanced expression of the Zip4 gene may occur in many different
cancers. We present evidence that ZIP4 can repress apoptosis and
enhance cell-cycle and cell migration. Therefore, ZIP4 can exert
profound effects on cancer growth and metastasis.
Results
The Zip4 Zinc Transporter Gene is Activated in Human
and Mouse Hepatocellular Carcinomas and May Also be
Activated in Many Different Cancers
We examined the expression of Zip4 in human hepatocellular
carcinomas (HCC). RNA extracted from a panel of biopsies of
human HCC and surrounding control tissue was analyzed by real-
time quantitative RT-PCR for Zip4 mRNA and values were
normalized to GAPDH mRNA (Table 1). Of the cancers
examined, 16 of 23 had elevated levels (.2-fold) of Zip4 mRNA
compared with surrounding control tissue and in several of the
HCC samples Zip4 mRNA was dramatically elevated (10- to 77-
fold). Similar results were obtained by normalizing Zip4 mRNA
values with those of another internal control HPRT1 mRNA
values (data not shown). The presence of ZIP4 protein in human
HCC was confirmed by immunofluorescence detection in frozen
sections (Fig. 1A). Cancerous tissues stained intensely for ZIP4
whereas surrounding cells and normal liver did not (Fig. 1A; see
normal liver tissue 3 and Patient 3). Many hepatoadenoma/
carcinoma cells within tumor tissues stained very intensely for
ZIP4 (Fig. 1A; see top left panel, Patient 4). ZIP4 was also detected
in hepatocytes from several of the samples which did not appear to
have elevated Zip4 mRNA (see Fig. 1; patient 11). Histological
examination of liver sections from patients 3 and 4 (Fig. 1B)
confirmed that ZIP4 positive cells were within well-circumscribed
lesions which primarily contained hepatoadenoma/carcinoma
cells, although we cannot exclude the possibility that some other
cell-types may also express Zip4 in these tumors.
Expression of Zip4 in a mouse model of HCC was also
examined, using FXR-knockout mice. FXR is a nuclear receptor
essential for maintaining bile acid homeostasis. The FXR-knockout
mice show increased bile acids and liver injury [24]. FXR
deficiency in mice results in spontaneous liver carcinogenesis with
hepatic adenoma, adenocarcinoma, and cholangiocyte carcinoma
when reaching 8 to 10 months of age in both genders [24,25]. In
FXR-knockout mice older than 12 months, the incidence of liver
tumor is 100% with the majority of the tumors being
hepatocellular adenoma followed by hepatocellular carcinoma.
The hepatocellular adenomas are characterized as well-circum-
scribed lesions with well-differentiated hepatocytes, whereas the
hepatocellular carcinoma consist of both hepatocellular and
cholangiocellular components.
Northern blot hybridization of RNA from normal liver and
tumors from these mice (15 months old) revealed high levels of
Zip4 mRNA in 4 out of 5 of the tumor samples and the abundance
of this mRNA in those tumors was similar to that found in mouse
Hepa cells. In contrast, Zip4 mRNA was rare in the normal liver
samples (Fig. 2A) as reported previously [26]. The presence of
ZIP4 protein in mouse HCC was confirmed by immunohisto-
chemical detection in paraffin sections (Fig. 2B). Groups of cells
staining intensely for ZIP4 were readily detected in all 5 tumor
samples (one is shown in Fig. 2B), but no ZIP4 staining was
detected in sections of normal liver (Fig. 2B; top panels) or in the
cells surrounding the tumors in FXR-knockout mice (Fig. 2B;
bottom panels). ZIP4 localization was restricted to the plasma
membrane of hepatocytes within well-circumscribed lesions
suggesting that these were hepatocellular adenomas (Fig. 2B).
Table 1. Aberrant Expression of Zip4 (Slc39a4) in Human HCC.
Zip4 mRNA (x 10-2)* Fold Increase
Patient No. (Normal) (Tumor) (Tumor/Normal)
1 2.07 22.04 10.65
2 0.37 5.92 16.00
3 0.95 11.83 12.45
4 0.70 17.22 24.60
5 5.71 7.38 1.29
6 1.93 1.74 0.90
7 0.35 1.53 4.37
8 2.40 4.79 1.99
9 0.86 4.90 5.70
10 6.07 15.34 2.53
11 1.65 1.24 0.75
12 0.86 10.91 12.68
13 1.22 9.98 8.18
14 0.60 46.23 77.05
15 0.51 2.45 4.80
16 0.77 1.43 1.85
17 2.07 0.79 0.38
18 1.38 7.99 5.79
19 0.91 2.51 2.76
20 0.25 2.23 8.92
21 1.06 1.06 1.00
22 0.45 1.03 2.28
23 0.08 1.18 14.75
*Relative Zip4 mRNA levels were normalized to that of GAPDH and are
presented as 2‘(CtGAPDH-CtZIP4).
doi:10.1371/journal.pone.0013158.t001
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The majority of hepatocytes within these lesions displayed ZIP4
localization restricted to what appears to be the apical surface
juxtaposed to a lumen, suggesting that these are well differentiated
hepatocytes (Fig. 2B).
The finding that Zip4 is aberrantly expressed in human and
mouse HCC, as well as in pancreatic adenocarcinoma, suggested
that Zip4 expression might also be increased in other carcinomas.
A meta-analysis of microarray data deposited in the Geo and
Oncomine databases for Zip4 (Slc39a4) expression supported this
hypothesis (Table 2). In the Geo database many Slc39a4 data sets
did not reveal significant differences between normal and cancer
samples, but evidence suggested elevated Zip4 mRNA is found in
some lymphoma, melanoma and metastatic colon cancer data sets
and in data sets from two mouse models of HCC (Mdr2 knockout
and Trnip transgenic). In the Oncomine database Zip4 was found
to be among the top 10% of genes expressed in many human
cancer types and was often associated with an aggressive stage of
the cancer. Expression in human HCC was also confirmed. This
meta-analysis suggests, but does not prove, that active expression
of Zip4 may occur in many different carcinomas. However, these
analyses did confirm and extend our independent finding of active
Zip4 expression in HCC from humans and mice.
Expression of the Zip4 Gene Reduces Apoptosis,
Modestly Enhances Reentry into the Cell Cycle after
G0/G1 Block When Zinc is Deficient, and Enhances Cell
Migration
To examine the functions of ZIP4 in HCC, we determined the
effects of Zip4 knockdown on apoptosis and progression through
Figure 2. Detection of Zip4mRNA and ZIP4 protein in HCC from
FXR-knockout and wild-type mice. Part A: HCC from FXR-knockout
mice (FXR KO; 15 months of age) and normal liver from wild-type (WT)
litter mates were analyzed by Northern blot hybridization to detect Zip4
mRNA in total RNA. Actin mRNA served as a loading control in the
Northern blots and staining of 28S and 18S rRNA served as a control for
integrity and quantity of RNA loaded. Part B: Immunohistochemical
detection of ZIP4 in paraffin sections of HCC from FXR-knockout and
wild-type mice. Arrow is pointing to the boundary of a well-
circumscribed lesion containing ZIP4-positive hepatocytes in the FXR-
knockout liver. Brown deposits indicate ZIP4 staining. Blue color
indicates hematoxylin stained nuclei.
doi:10.1371/journal.pone.0013158.g002
Figure 1. Immunofluorescence detection of ZIP4 in human
HCC. Part A: Frozen sections of HCC from patients 3, 4 and 11 and
normal liver tissue from patient 3 (see Table 1) were fixed, permeablized
and blocked then ZIP4 was detected using an antipeptide antibody
against mouse ZIP4 [26,47]. The peptide immunogen is well conserved
between mouse and human and specificity of this antibody has been
established [26,27,46]. Sections were washed and incubated sequen-
tially with biotinylated secondary antibody then QDot 655 streptavidin
conjugate. Red indicates the presence of ZIP4 whereas blue indicates
nuclei stained with DAPI. Adobe Photoshop image capture software
was used to capture these images. Part B: Frozen serial sections from
patients 3 & 4 stained with hematoxylin and eosin to reveal the cellular
structure of the ZIP4 positive tumors. Arrows point to the boundary of
well-circumscribed lesions containing ZIP4 positive hepatocytes.
doi:10.1371/journal.pone.0013158.g001
Expression of Zip4 in Cancers
PLoS ONE | www.plosone.org 3 October 2010 | Volume 5 | Issue 10 | e13158
the cell cycle in mouse Hepa cells. These cells actively express the
Zip4 gene and regulate the stability of this mRNA and the
endocytosis and processing or turn-over of this protein in response
to zinc [27,28]. ZIP4 protein is present at a low level in Hepa cells
under zinc-adequate culture conditions but accumulates during
zinc-deficiency (Fig. 3). Mouse Hepa cells were infected with
lentivirus vectors which express two RNAi sequences against
mouse Zip4 mRNA or a scrambled control RNAi, and infected
cells were purified by FACS using GFP expression from the viral
vector. Western blot analysis of membrane proteins from these
cells revealed that Zip4 RNAi effectively reduced ZIP4 protein
levels and largely prevented induction in response to zinc-
deficient culture conditions, but had no effect on ZIP1
abundance (Fig. 3). The control RNAi did not alter ZIP4
abundance or effect induction of this protein during zinc-
deficiency (Fig. 3).
Zip4 RNAi and control RNAi Hepa cells, purified by flow
sorting, were seeded at low density to facilitate a rapid onset of
zinc deficiency, blocked using hydroxyurea to increase the number
of cells in G0/G1, and then released from the block to reinitiate the
cell cycle in zinc-deficient medium (Fig. 4). The number of cells in
the various parts of the cell cycle was monitored by FACS at
various times up to 24 hr (Table 3). After release from the
hydroxyurea block into zinc-adequate medium, Zip4 RNAi and
control RNAi Hepa cells both progressed through the cell cycle at
essentially indistinguishable rates (data not shown). In contrast,
when released into zinc-deficient medium, cells expressing Zip4
RNAi reentered the cell cycle more slowly than did those
expressing control RNAi. At every time point examined the
percentage of cells in S phase after release from the block was
lower in the Zip4 RNAi cells compared with the control RNAi cells
(Fig. 4B) while the percentage of cells in G2 was greater in the Zip4
RNAi cells compared with the control RNAi cells (Fig. 4B & C
and Table 3). These data suggest that Zip4 expression enhances
cell cycle in Hepa cells. In addition to these findings, cultures
expressing Zip4 RNAi displayed a 2 to 3-fold increase in the sub-
G1 fraction, indicative of apoptotic cells with fragmented nuclear
DNA [29], after release into zinc-deficient medium (Fig. 4D and
Table 3). In contrast to these results, expression of Zip4 RNAi or
control RNAi did not affect reentry into the cell cycle after a G2/
M block using nocodazole, regardless of whether cells were
released into zinc-adequate or zinc-deficient medium (data not
shown).
The potential functions of ZIP4 in hepatoma cells was
investigated using Hepa cells that express control RNAi or Zip4
RNAi, as well as these cells transiently transfected with a human
Zip4 cDNA expression vector encoding human ZIP4 with a
carboxyl-terminal HA tag (Fig. 5A & B). Human Zip4 mRNA
would not be targeted efficiently by the RNAi against mouse
Zip4. Forced expression of Zip4 has been recently reported to
increase cell proliferation, tumor volume and metastasis of
pancreatic cells in vivo [13]. Herein, the ability of Hepa cells to
migrate through a fibronectin-coated membrane was monitored.
Hepa cells expressing control RNAi migrated through mem-
branes more efficiently than did those expressing Zip4 RNAi
(Fig. 5A &B). Forced expression of human Zip4-HA in Hepa cells
enhanced migration. Expression of human Zip4-HA in Hepa cells
which also express Zip4 RNAi against mouse Zip4 restored
migration activity, whereas it further augmented migration
activity of Hepa cells expressing control RNAi. In parallel
experiments we employed a well-established system using MCF-7
breast cancer cells which display a low background of cell
migration in vitro [30]. In these cells, expression of Zip7 has been
shown to enhance migration [31] and Zip4 is not expressed at
significant levels [32]. Herein, MCF-7 cells were transiently
transfected with an expression vector for mouse Zip4 with a
carboxyl-terminal HA tag [33]. The results show that forced
expression of mouse Zip4 also increased the migration of MCF-7
cells under these experimental conditions (Fig. 5C). These
transfection experiments underestimate the effects of forced
Table 2. Increased Expression of Zip4 (Slc39a4) May also
Occur in Many Different Cancers.
Database Tumor type Descriptor
Geo* Diffuse large B-cell lymphoma Mouse Brd2 transgenic
Metastatic colon cancer Human
Melanoma Human
HCC Mouse Trnip transgenic
HCC Mouse Mdr2 knockout
Oncomine** Breast Estrogen receptor positive
(Human) Breast Grade 3
Colon (see Bittner data set)
Colorectal (see Bittner data set)
Gastric (see Bittner data set)
Ovarian (see Bittner data set)
Peritoneal (see Bittner data set)
Cervical poorly differentiated
HCC Grade 4; poorly differentiated
Lung Grade 4
Prostate Grade 8–10; Grade 4
Esophagus Carcinoma
*Zip4 mRNA elevated in microarray compared with control. http://www.ncbi.
nlm.nih.gov/geo.
**Top ten percent of genes expressed in a truncated listing of tumors as
described/listed.
doi:10.1371/journal.pone.0013158.t002
Figure 3. Western blot analysis of RNAi knockdown of Zip4 in
mouse Hepa cells. RNAi (two RNAi sequences) against mouse Zip4
(Z4) and a scrambled RNAi control (Con) were expressed from the U6
promoter in lentivirus vectors that also express GFP driven by the PGK
promoter. Cells were infected and then purified for GFP expression by
FACS. Lentivirus infected cells and uninfected Hepa cells (-) were then
cultured for 24 hr in zinc-adequate medium (N) which contains normal
FBS or zinc-deficient medium (CX) which contains Chelex-treated FBS.
Membrane preparations from these cells were then fractionated by
SDS-PAGE, transferred to a membrane, and ZIP4 was detected using an
antipeptide antibody against mouse ZIP4. A prominent ,73 kDa ZIP4
band was detected (predicted size) as well as a larger ZIP4 aggregate.
ZIP1 was detected as a loading control (bottom panel). In Hepa cells a
non-specific (NS) band, which is predominately cytosolic, was detected
in these membrane preparations.
doi:10.1371/journal.pone.0013158.g003
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expression of mouse or human Zip4-HA since all of the cells were
not transfected in these cultures. Taken together the above results
demonstrate that ZIP4 can enhance cell migration.
Discussion
Studies reported herein demonstrate that the essential zinc
transporter ZIP4 is actively expressed in hepatocellular carcinoma
(HCC) and may well be expressed in many other types of cancer.
HCC is the fifth most common cancer in the world and third
leading cause of cancer deaths resulting in over 600,000 deaths
globally per year. The 5 year survival rate is reported to be below
5% (Reviewed by [34]). Thus, the finding of constitutively high
levels of Zip4 mRNA and protein in HCC, as well as in many
cancers in humans, is intriguing and may represent a potential
therapeutic target. Taken together with the recent demonstration
that ZIP4 is aberrantly expressed in pancreatic carcinoma [13],
our finding that Zip4 mRNA and protein also accumulate in HCC
suggests that aberrant activation of the Zip4 gene may play a
fundamental role in tumorigenesis.
How expression of the Zip4 gene is turned-on in cancer cells is
unknown. Active Zip4 gene expression is normally highly cell-type
specific [26], although very low level expression in some cultured
cells has been detected by RT-PCR [35]. In the normal mouse
liver Zip4 mRNA is rare and unresponsive to dietary zinc [26,27].
In contrast, Zip4 mRNA abundance and protein stability are both
regulated by several zinc-dependent post-transcriptional mecha-
nisms in cells that actively express this gene (enterocytes, visceral
endoderm, Hepa cells) [36]. Both mRNA and protein abundance
are repressed when zinc is replete, whereas accumulation of ZIP4
protein at the apical surface of enterocytes and visceral endoderm
cells and accumulation of Zip4 mRNA occurs when zinc is
deficient. The finding that ZIP4 localizes to what appears to be the
apical surface of hepatocytes in the liver tumors from FXR-
knockout mice suggests that either this protein is not zinc-
regulated in those cells or that these cells are zinc deficient. Several
studies have reported that HCCs have significantly lower levels of
zinc than the surrounding tissues (Reviewed by [34]) which is
consistent with the latter hypothesis. Whether this may also be the
case for other cancers which may express ZIP4 is not known.
Aberrant expression of Zip4 has been previously documented in
pancreatic ductal carcinoma, but the localization of ZIP4 in those
cancers was not reported [13].
Our studies revealed that when zinc is deficient ZIP4 functions
to repress apoptosis and may enhance reentry of hepatoma cells
into the cell cycle following release from a G0/G1 block. How
ZIP4 exerts these functions can be deduced from the fact that
ZIP4 is essential for the acquisition of dietary zinc in humans, and
Figure 4. FACS analysis of the effects of Zip4 knockdown on Hepa cell apoptosis and reentry into the cell cycle after release from
hydroxyurea into zinc-deficient medium. Hepa cells expressing Zip4 RNAi (Z4 RNAi) or control RNAi (Con RNAi) from lentivirus vectors were
purified for GFP expression by FACS. Confluent cultures were replated at low density (1:10) in zinc-deficient medium (DMEM plus 10% Chelex-treated
FBS), and blocked overnight in G0/G1 using hydroxyurea. The medium was replaced with fresh zinc-deficient medium and progression through the
cell cycle was quantified at the indicated times after release. Cell cycle parameters were monitored by propidium iodide staining followed by FACS.
The percentage of cells in each phase of the cell cycle is presented within each FACS scan. Part A: Cells in G0/G1. Part B: Cells in S phase. Part C:
Cells in G2/M. Part D: Cells in the sub-G1 fraction which is indicative of apoptotic cells. Data are expressed as the mean6 S.D. *Indicates a significant
difference between Zip4 RNAi and control RNAi (P,0.001).
doi:10.1371/journal.pone.0013158.g004
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for the transfer of zinc into the post-implantation conceptus and
for resistance to zinc deficiency in mice [20]. Therefore, ZIP4
likely serves a fundamental role to facilitate zinc uptake in some
tumors. Pancreatic cancer cells that over-express ZIP4 have
higher zinc levels than do normal pancreatic cells and display
increased in vitro proliferation and growth in nude mice [13]. A
relationship between zinc, apoptosis and cell proliferation has
been known for over 15 years [37–39]. Zinc can regulate cas-
pases and apoptosis in a cell-type and concentration dependent
manner [11]. Zinc deficiency can increase DNA damage and
alter the expression of genes involved in cell cycle, apoptosis and
DNA damage response and repair [38], as well as cause
increased apoptosis in developing rat embryos [40] and in the
skin [41]. Increased zinc stimulates DNA synthesis in embryonic
stem cells [42] and attenuates apoptosis in human hepatoma cells
in culture [43]. Taken together these findings support the
concept that ZIP4 facilitates zinc uptake which, in turn, en-
hances DNA replication and repair and reduces apoptosis.
Consistent with this concept knockdown of Zip4 using RNAi in
pancreatic cancer cells inhibited their growth in nude mice [14].
Other zinc transporters may serve the function of zinc uptake in
some cancers.
Forced expression of either human or mouse Zip4 was found
herein to enhance the in vitro migration of Hepa cells and MCF-7
cells, respectively. In contrast, repressed expression of Zip4
attenuated in vitro migration of Hepa cells. These findings are
consistent with recent reports that forced expression of Zip4 in
pancreatic cancer cells increases tumor volume and metastasis in
nude mice [13], whereas knockdown of Zip4 in pancreatic cancer
cells is associated with decreased cell proliferation, migration and
invasion [14]. Taken together these studies provide strong
support for the concept that ZIP4 serves a fundamental role in
cancer.
The molecular mechanisms by which ZIP4 and zinc control
growth and migration of cancer cells likely involves multiple
signal transduction cascades. The effects of zinc and zinc
transporters on signal transduction cascades appear to be, in
part, cell-type specific. For example, mutations in ZIP13 cause a
rare form of Ehlers-Danlos syndrome, and result in abnormal
development of connective tissues possibly due to changes in
signaling through the bone morphogenic protein/TGFb signaling
cascade [44]. In HeLa cells Zip6 over-expression enhances
SNAIL, a repressor of E-cadherin [18] and in Zebrafish zLIV-
1 (ZIP6-like) regulates SNAIL and enhances the epithelial-
mesenchymal transition during development [23]. Recent studies
of pancreatic cancer reported that ZIP4 activates the IL-6/Stat3
pathway via CREB, leading to increased expression of neuropi-
lin-1, vascular endothelial growth factor, and matrix metallopro-
teases [15,16]. Zinc has been shown to modulate FoxO signaling
in human hepatoma cells [43] and in mouse embryonic stem cells
zinc stimulates DNA synthesis through the PI3K/Akt, MAPKs
and mTOR pathways [42]. We noted that zinc availability can
control the abundance of b-catenin in two hepatoma cell lines
[Weaver and Andrews, unpublished observation]. Thus, ZIP4
enhanced zinc uptake may affect signal recognition, second
messenger metabolism, protein kinase and protein phosphatase
activities and transcription factor activity (Reviewed by [5,10]).
Whether ZIP4 has functions in addition to zinc uptake activity
remains to be determined and further studies are required to
delineate the mechanisms by which ZIP4 and other ZIP
family members can alter signal transduction cascades in cancer
cells.
Table 3. FACS Analysis of the Effects of ZIP4 Knockdown on Hepa cell Apoptosis and Progression after Release from Hydroxyurea
Block into Zinc-Deficient Medium*.
Time after Release Cell Cycle Phase Con RNAi (Mean%) (S.D.) Zip4 RNAi (Mean%) (S.D.)
0 h SubG1 0 0 0 0
G0/G1 48.27 1.47 54.255 1.23
S 49.21 1.30 37.855 2.17
G2/M 2.51 0.17 7.89 0.93
4 h SubG1 0 0 0 0
G0/G1 52.85 0.62 55.85 2.43
S 42.41 0.78 35.34 1.15
G2/M 4.73 0.15 8.80 1.28
10 h SubG1 5.96 0.92 11.7 0.72
G0/G1 44.90 0.95 50.31 1.55
S 53.89 0.45 44.185 1.47
G2/M 1.21 0.49 5.505 0.07
18 h SubG1 7.77 1.64 19.72 0.56
G0/G1 41.93 2.24 42.01 1.10
S 57.98 2.35 54.785 0.60
G2/M 0.08 0.11 3.205 0.50
24 h SubG1 6.38 0.60 15.35 1.37
G0/G1 36.08 1.08 46.07 0.69
S 63.68 0.74 47.49 1.93
G2/M 0.23 0.33 5.44 0.17
*Details of this experiment are presented in the legend to Figure 4 and in Materials and Methods.
doi:10.1371/journal.pone.0013158.t003
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Figure 5. Effects of RNAi knockdown of Zip4 and/or forced expression of Zip4 on the migration of Hepa and MCF-7 cells. Hepa cells
expressing Zip4 RNAi (Z4 RNAi) or control RNAi (Con RNAi) from lentivirus vectors were purified for GFP expression by FACS. Cells were seeded
onto fibronectin-coated Transwell inserts and allowed to migrate for a period of 16 h. Non-migratory cells were removed and cells that had migrated
through the membrane were fixed and stained with crystal violet. Cell migration was visualized by microscopy (Part A) and quantified by measuring
Expression of Zip4 in Cancers
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Materials and Methods
Ethics Statement
All experiments involving mice were conducted in accordance
with the National Institutes of Health guidelines for the care and
use of experimental animals and were approved by the
Institutional Animal Care and Use Committee (ACUP number
2007-1698: approved 1-19-2010).
Human HCC Specimens
HCC specimens were obtained through the LTCDS (Liver
Tissue Cell Distribution Service) under the NIH Contract – #
N01-DK-7-0004/HHSN267200700004C (Minneapolis, Minne-
sota) [45].
Real-Time PCR Quantification of Zip4 mRNA in Human
HCC
Total RNA was isolated from tumor and surrounding normal
tissue by Trizol extraction. Real-time PCR was performed using
total RNA and products were detected using the SYBR Green
PCR master mix (appliedbiosystems.com). PCR included the
following components: 100 nM of each primer, diluted cDNA
templates and SYBR green PCR master mix. Samples were
denatured at 95uC for 10 min and amplified for 40 cycles at 95uC
for 15 sec and 60uC for 1 min. The melting-curve data were
collected to confirm PCR specificity. Each cDNA sample was run
in triplicate, and the corresponding no-reverse transcriptase (RT)
mRNA sample was included as a negative control. The GAPDH
primers were included in every sample to control for sample
variation. Zip4 mRNA product in each sample was normalized to
that of the GAPDH mRNA. The amount of PCR products was
measured by threshold cycle (Ct) values and relative mRNA levels
are presented as unit values of 2 ˆ[Ct(GAPDH) -Ct(Zip4)]. The
primer sequences for human Zip4 mRNA (Slc39a4) were: sense 59
AAGCACTGCTGCTGAACCTGGCCT 39; and antisense 59
GATGTCATCCTCGTACAGGGACAGCAGC 39. The primer
sequences for the human GAPDH mRNA were: sense 59 ACA-
TCATCCCTGCCTCTACTGG 39; and antisense 59 TCCGA-
CGCCTGCTTCACC 39.
Immunofluorescence and Immunohistochemical
Detection of ZIP4, and Histology of Human HCC Tissue
Frozen sections of human HCC and normal liver were thawed
directly into phosphate-buffered saline (PBS) containing freshly
prepared 2% paraformaldehyde and 0.1% Triton-X-100 for
30 min at room temperature. Sections were washed with PBS and
incubated in PBS containing 50 mM lysine for 30 min to quench
autofluorescence. Sections were washed in PBS, incubated in PBS
containing 0.1% Triton-X-100/0.1% Tween 20 for 20 min,
blocked with 10% normal goat serum in PBS for 1 hr and ZIP4
was detected, as described previously, using an antipeptide
antibody against mouse ZIP4 [26]. The peptide immunogen is
well conserved between mouse and human and specificity of this
antibody has been established [26,27,46]. Sections were washed
thoroughly with PBS and incubated sequentially with biotinylated
secondary antibody (1:500; jacksonimmuno.com) and QDot 655
streptavidin conjugate (1:500; invitrogen.com). Slides were mount-
ed with glycerol containing 49,6-diamidino-2-phenylindole (DAPI)
to stain nuclei and visualized using a Leica DM 4000B (Leica-
microsystems.com) with Adobe Photoshop image capture software
(adobe.com). For histology of human HCC, frozen serial sections
from tissues assayed by immunofluorescence (above) were thawed
directly in PBS containing freshly prepared 4% paraformaldehyde,
washed in PBS, stained with hematoxylin and eosin and
photographed using a Leica DM 4000B, as above.
Immunohistochemistry was employed to detect ZIP4 in FXR-
knockout mouse livers and normal liver using the Zymed
Laboratories Inc. Histostain-SP kit (invitrogen.com) for rabbit
primary antibody and diaminobenzidine substrate staining, as
described previously [47]. Tissues were fixed overnight in 4%
paraformaldehyde, embedded in paraffin, and sectioned. Sections
were deparaffinized, and subjected to antigen retrieval in 10 mM
citrate (pH 6.0) at 95uC for 10 min. Sections were then treated
with 1% peroxide, blocked with 10% normal goat serum, and
incubated with the primary antiserum (1:600 dilution). Sections
were washed with PBS, incubated with biotinylated secondary
antibody followed by streptavidin-conjugated horseradish perox-
idase and then developed in diaminobenzidine. Slides were then
stained with hematoxylin and photographed using a Leica DM
4000B with Adobe Photoshop image capture software.
A Farnesoid X Receptor (FXR)-Knockout Mouse Model of
HCC
The FXR-knockout mice were generated and back-crossed into
the C57BL/6 genetic background, as described previously [24].
The genotype was confirmed by a PCR-based genotyping
protocol. Mice were allowed free access to water and food and
were exposed to a 12 hr light/12 hr dark cycle. Livers were
removed from 15-month old male mice and snap-frozen in liquid
nitrogen or frozen in OCT-compound.
Northern Blot Hybridization
Total RNA (3–6 mg) was isolated, size-fractionated by agarose-
formaldehyde gel electrophoresis and transferred and UV cross-
linked to nylon membranes, as described in detail previously
[48,49]. Northern blot membranes were hybridized and washed
under stringent conditions. Hybrids were detected by autoradiog-
raphy at 280uC. Duplicate gels were stained with acridine orange
to ensure equivalent loading and integrity of total RNA. Probes for
mouse Zip4 and actin mRNAs were as described [47]. Probes were
used at 26106 cpm/ml of hybridization solution.
Zinc-Adequate and Zinc-Deficient Cell Culture Conditions
Mouse Hepa cells were maintained at 37uC in a humidified 5%
CO2 incubator in Dulbecco’s modified Eagle medium (DMEM)
containing 10% heat-inactivated fetal bovine serum (FBS), 100
the absorbance of cell lysates at 595 nm (Part B). In parallel, Hepa cells expressing Zip4 RNAi or control RNAi were transfected with a human Zip4-HA
expression vector (Z4HA), serum starved overnight and then seeded onto Transwell inserts and allowed to migrate for 16 h. Migratory cells were
visualized and quantified as described above. ** Indicates a significant difference from control RNAi and/or Z4 RNAi, left two bars (P,0.001) and #
indicates a significant difference from control RNAi and/or Z4 RNAi/Z4HA (P,0.001). Part C: MCF-7 cells were transfected with an expression vector
for mouse Zip4-HA [33] (Z4HA), or exposed to transfection reagent without vector (control), and then seeded onto fibronectin-coated Transwell
inserts. Cells were allowed to migrate for a period of 16 h, non-migratory cells were removed and cells that had migrated through the membrane
were fixed and stained. Cell migration was quantified by counting the numbers of cells in 5 randomly-chosen fields of view per membrane (n$3 for
each treatment) and results are plotted as the mean cell migration (percent of control 6 S.D.). ** Indicates a significant difference between control
and Z4HA transfected MCF-7 cells (P,0.001).
doi:10.1371/journal.pone.0013158.g005
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units penicillin/ml, and 100 mg streptomycin/ml. To generate
zinc-deficient conditions in culture, heat-inactivated fetal bovine
serum (FBS) was treated with Chelex-100 resin, as described [33].
Essential metals except zinc were repleted by the DMEM which
was adjusted to 10% Chelex-treated FBS. Cells were plated at a
density of 56104 cells per 10 cm plate in either zinc-adequate
(normal FBS) or zinc-deficient (Chelex-treated FBS) medium.
Zip4 RNAi Lentivirus Construction
Zip4 RNAi and control RNAi lentiviral constructs were created
in third generation lentiviral vectors, amplified in HEK293 cells,
purified by centrifugation, and titered in the Washington
University Core Facility as described [50]. The packaging genes
were separated on two plasmids which lack both LTRs and have
no viral packaging signal. The following viral genes were deleted
from the packaging vector: env, vpr, vpu, vif and nef. This vector has
a self-inactivating LTR and envelope, VsVg, is expressed on a
separate plasmid [51]. The RNAi against mouse Zip4 and the
scrambled RNAi control were expressed from the U6 promoter;
this vector also expressed green fluorescence protein (GFP) driven
by the PGK promoter. The oligos listed below were annealed,
phosphorylated, and ligated into this vector just downstream of the
U6 promoter at the AarI site.
Zip4 RNAi
Zip4sh468 duplex. 59 ACCGGGAGAAGACCTGTGTA-
GATCTCTTCCTGTCAAGATCTACACAGGTCTTCTCC 39
39 CCTCTTCTGGACACATCTAGAGAAGGACAGTTCT-
AGATGTGTCCAGAAGAGGAAAA 59
Zip4sh1332 duplex. 59 ACCGGGACCAGGATTCTGAG-
AAAGACTTCCTGTCATCTTTCTCAGAATCCTGGTCC 39
39 CCTGGTCCTAAGACTCTTTCTGAAGGACAGTAGA-
AAGAGTCTTAGGACCAGGAAAA 59
Scrambled control RNAi
shScrTop. 59 ACCGGCGCCTAATTGTCTGGACTATC-
TTCCTGTCAATAGTCCAGACAATTAGGCGC 39
shScrBottom. 59 AAAAGCGCCTAATTGTCTGGACTA-
TTGACAGGAAGATAGTCCAGACAATTAGGCGC 39
Lentivirus Infection and Purification of Mouse Hepa Cells
Mouse Hepa cells were incubated with Zip4 RNAi and control
RNAi lentiviruses at a multiplicity of infection of 5:1 overnight.
Cells were washed extensively and then incubated for 24 hr in
DMEM containing 10% FBS. A single cell suspension of these
cells was prepared in PBS containing 20% FBS and analyzed by
fluorescence activated cell sorting (FACS) for GFP expressed from
the lentivirus construct. Fluorescence in the GFP channel was
monitored and the intensity of autofluorescence in the wild-type
cells was used to define the base line fluorescence. Cells with signal
intensities clearly greater than that value were collected and used
for experiments. At least 95% of the flow sorted cells were GFP
positive.
Western Blot Detection of ZIP4
Membrane proteins were prepared from Hepa cells and
analyzed as described [27,47]. Membrane proteins (20 to 25 mg)
were resolved by 8% SDS-polyacrylamide gel electrophoresis
(PAGE) and transferred to polyvinylidene difluoride membranes.
Membranes were blocked overnight and then incubated with
primary antibody in blocking solution at the appropriate dilution
(ZIP4 antiserum 1:800; ZIP1 antiserum 1:800) for 2 hr at room
temperature. After extensive washing, membranes were incubated
with goat anti-rabbit horseradish peroxidase-conjugated secondary
antibody and the blot was developed using ECL Plus reagent
(amershambiosciences.com) according to manufacturer’s instruc-
tions and detected using Kodak BioMax MS film (kodak.com).
Cell Cycle Analysis by FACS
Hepa cells expressing Zip4 RNAi or control RNAi were split
1:10 from confluent cultures into zinc-adequate or zinc-deficient
medium and then blocked in G0/G1 by incubating for 16 hr with
100 mM hydroxyurea (sigmaaldrich.com) or blocked in G2/M by
incubating for 16 hr with 0.1 mg/ml nocodazole (sigmaaldrich.-
com). The blocking medium was then replaced with zinc-adequate
or zinc-deficient medium to allow cells to progress in the cell cycle,
and cells were harvested at different times thereafter. Cell cycle
parameters were monitored by propidium iodide (PI) staining
followed by FACS using an Epics XL Flow Cytometer
(beckman.com) [52].
ZIP4 and Cell Migration Assay
Hepa cells expressing Zip4 RNAi or control RNAi were plated
onto 60 mm dishes and transfected with 4 mg of a human Zip4-HA
expression vector or pcDNA3.1 control vector using Lipofecta-
mine 2000 (invitrogen.com) in antibiotic free media according to
the manufacturer’s instructions. After 6 h the cells were serum
starved for 24 h and 56104cells were seeded onto Transwell
inserts (8 mm pore size; Culterx 96 well cell migration assay:
amsbio.com). Cells were allowed to migrate for 16 h after which
the non-migratory cells were removed from inside the chamber
with a cotton swab. Cells that had migrated through the
membrane pores were fixed for 10 min (3.7% v/v formaldehyde
in PBS), stained with 0.1% crystal violet for 15 min, washed with
PBS, and photographed using a Microfire/Qcam CCD Olympus
1681 microscope. Crystal violet stained cells were lysed in 1%
SDS for 30 min and absorbance of the lysate was measured at
595 nm in a plate reader (BioTek, synergy HT: biotek.com).
Results were plotted as the mean absorbance 6 S.D.
MCF-7 cells were seeded at 26105/cm2 and grown until 80%
confluent in phenol-red-free RPMI supplemented with 5% fetal
calf serum, 200 mM L-glutamine, 10 IU/ml penicillin, 10 mg/ml
streptomycin, and 2.5 mg/ml fungizone. Cells in 60 mm dishes
were transfected with 8.8 mg of an expression vector for mouse
Zip4-HA [33] and 27.5 ml of Lipofectamine 2000 (invitrogen.com)
in antibiotic free media according to the manufacturer’s
instructions. As a control, cells were exposed to Lipofectamine
2000 without expression vector. After 6 hr the cells were counted
and 26104 cells were seeded onto fibronectin-coated (1 mg/ml)
Transwell inserts (8 mm pore size; bdbiosciences.com). Cells were
allowed to migrate for a period of 16 h after which the non-
migratory cells were removed from inside the chamber with a
cotton swab. Cells that had migrated through the membrane pores
were fixed (3.7% v/v formaldehyde in PBS) and stained with
crystal violet. Cell migration was quantified by counting the
numbers of cells in 5 randomly-chosen fields of view per
membrane (n$3 for each treatment) and results were plotted as
the mean cell migration (percent of untreated cells 6 S.D.).
Meta-Analyses of Zip4 mRNA Microarray Data Deposited
in the Geo and Oncomine Public Databases
The Geo microarray database at the NCBI was accessed at the
following URL: http://www.ncbi.nlm.nih.gov/geo. This database
was queried for Gene Profile of Slc39a4 and cancer, at the time of
submission of this manuscript, which yielded 106 hits; Slc39a4 and
hepatocellular carcinoma which yielded 5 hits; Slc39a4 and
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lymphoma which yielded 21 hits, Slc39a4 and colon cancer which
yielded 5 hits; and Slc39a4 and melanoma which yielded 18 hits.
Among these data sets several cancers which showed increased
expression of Zip4 mRNA were noted. The Oncomine database
was accessed at the following URL: http://www.oncomine.org.
This database was queried for Slc39a4 among the top ten percent
of genes expressed in tumors.
Statistical Analyses
Data were analyzed using the Students’-T-Test to determine P
values. Data are expressed as the mean 6 Standard Deviation
(S.D.)
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